How has been the historical performance of Dr Reddy's Labs?

Answer:The historical performance of Dr Reddy's Labs shows a consistent growth trajectory in net sales and profit over the years, culminating in the fiscal year ending March 2025.

Breakdown:
Dr Reddy's Labs has demonstrated significant growth in net sales, increasing from 17,517.00 Cr in March 2020 to 32,643.90 Cr in March 2025. This upward trend is mirrored in total operating income, which also rose from 17,517.00 Cr to 32,643.90 Cr during the same period. The company has effectively managed its expenditures, with total expenditure (excluding depreciation) growing from 15,046.60 Cr in March 2020 to 24,096.80 Cr in March 2025, while operating profit (PBDIT) surged from 3,091.00 Cr to 9,644.40 Cr. Profit before tax followed suit, climbing from 1,829.60 Cr to 7,657.80 Cr, and profit after tax increased from 1,969.90 Cr to 5,703.50 Cr. The net profit for the company reached 5,655.10 Cr in March 2025, up from 1,950.00 Cr in March 2020. The total assets of Dr Reddy's Labs have also expanded significantly, rising from 22,005.40 Cr in March 2020 to 47,594.10 Cr in March 2025, while total liabilities increased from 22,005.40 Cr to 47,594.10 Cr. The cash flow from operating activities has shown a positive trend, with a cash flow of 4,642.00 Cr in March 2025 compared to 2,984.00 Cr in March 2020. Overall, Dr Reddy's Labs has exhibited strong financial performance, characterized by increasing revenues, profits, and asset growth over the years.